急性白血病中性粒细胞减少性发热前肠道菌群与宿主代谢交互的改变
尽管接受抗生素预防,多数接受黏膜毒性化疗的急性白血病患者仍出现中性粒细胞减少性发热(NF),许多病例病因不明。研究对2个急性白血病患者队列进行肠道菌群纵向分析,发现肠道阿克曼菌属(Akkermansia)扩张与NF风险增加相关;血清代谢组分析显示与阿克曼菌属及NF相关的特征在γ-谷氨酰循环代谢物上重叠,提示氧化应激介导。肠道微生物衍生的吲哚化合物在阿克曼菌属扩张后升高、NF前降低。
要点
- 肠道阿克曼菌属扩张与急性白血病患者中性粒细胞减少性发热风险增加相关。
- 阿克曼菌属相关与NF相关的血清代谢特征在γ-谷氨酰循环重叠,提示氧化应激介导。
- 肠道微生物衍生吲哚化合物在阿克曼菌属扩张后升高、NF前降低,可能介导抗炎效应。
核心结论
- 阿克曼菌属通过调节黏膜界面影响菌群-宿主代谢交互,其扩张与NF风险增加相关。
- γ-谷氨酰循环代谢物重叠提示氧化应激是阿克曼菌属相关NF的介导因素。
- 肠道微生物衍生吲哚化合物可能在阿克曼菌属抗炎效应中发挥作用。
研究设计与样本
- 对2个急性白血病患者队列进行肠道菌群纵向分析。
- 对血清代谢组进行纵向分析。
- 试验注册号NCT03316456。
主要发现
- 肠道阿克曼菌属扩张与NF风险增加相关。
- 血清代谢组鉴定出与肠道阿克曼菌属相关的特征和与NF相关的特征,二者在γ-谷氨酰循环代谢物上重叠。
- 肠道微生物衍生吲哚化合物水平在阿克曼菌属扩张后升高、NF前降低。
临床怎么用
- 阿克曼菌属扩张及相关代谢通路可能作为NF精准治疗的靶点。
- 临床背景(包括影响菌群组成的因素)决定经肠道屏障吸收的代谢物类型及其对宿主的净效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite antibiotic prophylaxis, most patients with acute leukemia receiving mucotoxic chemotherapy develop neutropenic fever (NF), many cases of which remain without a documented etiology. Antibiotics disrupt the gut microbiota, with adverse clinical consequences, such as Clostridioides difficile infection. A better understanding of NF pathogenesis could inform the development of novel therapeutics without deleterious effects on the microbiota. We hypothesized that metabolites absorbed from the gut to the bloodstream modulate pyrogenic and inflammatory pathways. Longitudinal profiling of the gut microbiota in 2 cohorts of patients with acute leukemia showed that Akkermansia expansion in the gut was associated with an increased risk for NF. As a prototype mucolytic genus, Akkermansia may influence the absorption of luminal metabolites; thus, its association with NF supported our metabolomics hypothesis. Longitudinal profiling of the serum metabolome identified a signature associated with gut Akkermansia and 1 with NF. Importantly, these 2 signatures overlapped in metabolites in the γ-glutamyl cycle, suggesting oxidative stress as a mediator involved in Akkermansia-related NF. In addition, the level of gut microbial-derived indole compounds increased after Akkermansia expansion and decreased before NF, suggesting their role in mediating the anti-inflammatory effects of Akkermansia, as seen predominantly in healthy individuals. These results suggest that Akkermansia regulates microbiota-host metabolic cross talk by modulating the mucosal interface. The clinical context, including factors influencing microbiota composition, determines the type of metabolites absorbed through the gut barrier and their net effect on the host. Our findings identify novel aspects of NF pathogenesis that could be targets for precision therapeutics. This trial was registered at www.clinicaltrials.gov as #NCT03316456.
引用
- Rashidi A, Ebadi M, Rehman TU, et al. Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia. Blood Adv. 2021. PMID: 34478486. doi:10.1182/bloodadvances.2021004973
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。